Evaluation of in vitro inhibition and induction of cytochrome P450 activities by hydrolyzed ginkgolides

被引:14
作者
Zhou, Xiao-wen [1 ]
Ma, Zheng [2 ]
Geng, Ting [2 ]
Wang, Zhen-zhong [2 ]
Ding, Gang [2 ]
Bi, Yu-an [2 ]
Xiao, Wei [2 ]
机构
[1] Nanjing Univ Tradit Chinese Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[2] Jiangsu Kan Pharmaceut Co Ltd, State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Peoples R China
关键词
Hydrolyzed ginkgolides; Inhibition; Induction; CYP; mRNA expression; Enzyme activity; BILOBA EXTRACT; DRUG-INTERACTIONS; PHARMACOKINETICS; PHARMACODYNAMICS; INJURY;
D O I
10.1016/j.jep.2014.10.023
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relavance: The extracts of Ginkgo Hobo leaves are effective in treating cerebral infarction, of which ginkgolides have been demonstrated to be the active ingredients. The purpose of this study was to determine whether hydrolyzed ginkgolides would cause potential drug-drug interactions (DDI) during its clinical use via inhibition or induction of the major human cytochrome P450s (CYPs). Materials and methods: The inhibition (direct and metabolism-dependent inhibiton on CYP activities) and induction (mRNA expression level and activity of CYPs) by the hydrolyzed ginkgolides were evaluated in human liver microsomes and cryopreserved human hepatocytes, respectively. Results: Within 0.1 to 10 mu g/mL, the hydrolyzed ginkgolides showed negligible direct inhibition against CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4m (midazolam as substrate) and 3A4t (testosterone as substrate), with IC50 values determined to be > 10 mu g/mL (concentrations expressed as the sum of equivalent concentrations of ginkgolide A, B and K). For the metabolism-dependent inhibition studies, the preincubation of 30 min did not substantially alter the IC50 values when compared with the corresponding values in the direct inhibition studies. The activities and mRNA expression levels for CYP1A2 and 2B6 within each drug-treated group (0.1, 1 and 10 mu g/mL) were not affected after the 48-h incubation. For CYP3A4, the activity and mRNA expression level were not altered when incubated with 0.1 and 1 mu g/mL of hydrolyzed ginkgolides. When incubated with hydrolyzed ginkgolides at 10 mu g/mL, the relative activity and relative mRNA expression level of CYP3A4 remarkably increased to 4.59 +/- 3.67 and 17.2 +/- 9.16-fold of the corresponding vehicle control values, respectively. Conclusions: The hydrolyzed ginkgolides is not likely to cause DDI via inhibition of the major human CYPs. However, the CYP3A4 induction might be clinically relevant. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:132 / 139
页数:8
相关论文
共 22 条
[1]   Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β1-42 [J].
Bate, Clive ;
Salmona, Mario ;
Williams, Alun .
JOURNAL OF NEUROINFLAMMATION, 2004, 1 (1)
[2]  
Beck J C, 1991, Autoimmunity, V9, P225, DOI 10.3109/08916939109007648
[3]  
Deng Ying, 2008, Drug Metab Lett, V2, P60
[4]   Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans [J].
Gurley, BJ ;
Gardner, SF ;
Hubbard, MA ;
Williams, DK ;
Gentry, WB ;
Cui, Y ;
Ang, CYW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) :276-287
[5]   Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly -: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba [J].
Gurley, BJ ;
Gardner, SF ;
Hubbard, MA ;
Williams, DK ;
Gentry, WB ;
Cui, YY ;
Ang, CYW .
DRUGS & AGING, 2005, 22 (06) :525-539
[6]  
He Nu, 2004, Am J Ther, V11, P206, DOI 10.1097/00045391-200405000-00009
[7]   Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides:: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts [J].
Koch, E .
PHYTOMEDICINE, 2005, 12 (1-2) :10-16
[8]   Human Pregnane X Receptor Agonism by Ginkgo biloba Extract: Assessment of the Role of Individual Ginkgolides [J].
Lau, Aik Jiang ;
Yang, Guixiang ;
Rajaraman, Ganesh ;
Baucom, Christie C. ;
Chang, Thomas K. H. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (03) :771-780
[9]   Bioactive Terpenoids and Flavonoids from Ginkgo Biloba Extract Induce the Expression of Hepatic Drug-Metabolizing Enzymes Through Pregnane X Receptor, Constitutive Androstane Receptor, and Aryl hydrocarbon Receptor-Mediated Pathways [J].
Li, Linhao ;
Stanton, Joseph D. ;
Tolson, Antonia H. ;
Luo, Yuan ;
Wang, Hongbing .
PHARMACEUTICAL RESEARCH, 2009, 26 (04) :872-882
[10]   The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat [J].
Liu, XH ;
Eun, BL ;
Silverstein, FS ;
Barks, JDE .
PEDIATRIC RESEARCH, 1996, 40 (06) :797-803